We are pleased to announce that on May 27 at 18:00 there will be a meeting with Ilya Nechayev, the head of Oncology Department at Roche and the specialist in the field of BioMedtech startups. The meeting was organized by the Faculty of Biology and Biotechnology of HSE and will be held with the support of the NES BFS Club.
At the meeting, Ilya will talk about the full cycle of launching a new medicine to the market from the research and development to commercialization and pricing. The speaker will explain the basics of BioTech companies assessment, including specific risk-adjusted NPV methodology. This lecture aims to form a complete picture of this promising and fast-growing industry, which can be useful for the accurate analysis of BioTech companies and portfolios.
Ilya Nechayev is a Candidate of Medical Sciences, PhD and MBA (Kingston University & RANEPA) with over 8 years of experience in global pharmaceutical companies (such as Roche and The Janssen Pharmaceutical Companies of Johnson & Johnson). Ilya has extensive experience in the management of strategic projects, product launch, development and implementation of medical and marketing projects. He managed a portfolio of eight products in the field of oncological diseases, worth more than 220 million Swiss francs. Ilya also developed portfolio strategies for several pharmaceutical companies, such as Tecentriq and Alecenca. In 2018, Ilya became the winner of the manager competition «Leaders of Russia» (top-300 of 200,000 participants).
The meeting will be held offline and online. The translation will be held on the platform Zoom. The link to the conference will be sent by mail after registration before the meeting.